Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ImmunoPrecise Antibodies Ltd. - Common Stock (NQ:IPA)

1.530 +0.220 (+16.79%)
Streaming Delayed Price Updated: 10:25 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ImmunoPrecise Antibodies Ltd. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global... 
Via Benzinga
32 Stocks Moving in Friday's Pre-Market Session
Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported better-than-expected Q2 results. Acorda Therapeutics Inc (... 
Via Benzinga
Why ImmunoPrecise Antibodies Stock Is Soaring Today
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) is surging higher... 
Via Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company Inc. (NYSE: NWHM) climbed 83% to $8.90 after the... 
Via Benzinga
ImmunoPrecise SkyRockets On Delta Variant Therapy News: What's Next?
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) skyrocketed 136%... 
Via Benzinga
Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.16% to 34,853.89 while the NASDAQ rose 0.38% to 14,687.85. The S&P also rose, gaining 0.20% to 4,367.55. The U.S. has... 
Via Benzinga
Topics Stocks
61 Biggest Movers From Yesterday
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... 
Via Benzinga
IPA Stock: 7 Things to Know About Covid Vaccine Stock ImmunoPrecise as Shares Rocket 120%
Today's impressive move in ImmunoPrecise's stock price has led investors in IPA stock to consider what is driving these price changes. 
Via InvestorPlace
38 Stocks Moving In Thursday's Mid-Day Session
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... 
Via Benzinga
Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge
Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70. The U.S. has... 
Via Benzinga
Topics Stocks
Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates
Following the market opening Thursday, the Dow traded down 0.24% to 34,715.42 while the NASDAQ rose 0.13% to 14,651.19. The S&P also fell, dropping 0.08% to 4,355.29. The U.S... 
Via Benzinga
Topics Stocks
Immunoprecise Stock Soars As COVID-19 Antibody Cocktail Shows Neutralizing Activity Against Delta Variant In Animal Study
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity... 
Via Benzinga
ImmunoPrecise's PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was CoStar Gr (... 
Via Benzinga
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
From ImmunoPrecise Antibodies
Via Business Wire
Immunoprecise Share Are Trading Higher On Encouraging Preclinical Data Of COVID-19 Antibody Cocktail
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has announced additional results from its in vivo hamster challenge efficacy study of TATX-03a PolyTope Therapy, a four... 
Via Benzinga
Histopathology Preclinical Data from ImmunoPrecise’s Polytope™ Program Confirms Lung Inflammation Reduction
From ImmunoPrecise Antibodies
Via Business Wire
Preclinical Data from ImmunoPrecise’s Drug Pipeline to be Presented During the BIO International Partnering Event
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing
From ImmunoPrecise Antibodies
Via Business Wire
ImmunoPrecise Selects LifeSci Advisors as Investor Relations Agent of Record
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 32.67% to $67.0 during Friday's pre-market session. The company's market cap stands at $860.7... 
Via Benzinga
ImmunoPrecise Launches TATX-112 Antibody Program For Cancer, Alzheimer's Disease
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary Talem Therapeutics LLC has advanced developing a candidate referred to as TATX-112,... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers 180 Life Sciences (NASDAQ:ATNF) stock increased by 25.09% to $9.92 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease
From ImmunoPrecise Antibodies
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.